Skip to main content
Top
Published in: Journal of Neuro-Oncology 2/2007

01-06-2007 | Original Paper

Hyperdiploidy defines a distinct cytogenetic entity of meningiomas

Authors: Ralf Ketter, Yoo-Jin Kim, Simone Storck, Jörg Rahnenführer, Bernd F. M. Romeike, Wolf-Ingo Steudel, Klaus D. Zang, Wolfram Henn

Published in: Journal of Neuro-Oncology | Issue 2/2007

Login to get access

Abstract

Background

The most common chromosomal aberration found in meningiomas is monosomy 22. Progression and recurrence of meningiomas are usually associated with additional chromosome losses. Rarely, however, meningiomas have strongly hyperdiploid karyotypes with over 50 chromosomes; the objective of this study was to explore the cytogenetic and histopathologic patterns as well as the clinical significance of hyperdiploidy in meningiomas.

Methods

Within a series of 677 consecutive meningiomas, we identified a subgroup comprising 16 cases that display a strikingly uniform pattern of hyperdiploidy mostly without structural chromosome rearrangements, as shown by banding techniques and, in the single structurally aberrant case, spectral karyotyping.

Results

These meningiomas each have between 50 and 56 chromosomes, with trisomy 12 (14/16 cases), trisomy 20 (13/16 cases), trisomy 5 (12/16 cases), and trisomy 17 (10/16 cases). Histomorphologically, hyperdiploid meningiomas feature a heterogeneous phenotype. However, they are associated with a higher histological grade, and decreased expression of alkaline phosphatase as compared to meningiomas with typical karyotype. In two patients, recurrences were documented and three patients died of disease during the period of observation, indicating a worse prognosis of hyperdiploid than of cytogenetically typical meningiomas.

Conclusion

We conclude that hyperdiploidy constitutes a small but clinically relevant entity of biologically aggressive meningiomas, which are cytogenetically distinguishable from the majority of common-type meningiomas.
Literature
2.
go back to reference Bello MJ, de Campos JM, Vaquero J, Kusak ME, Sarasa JL, Rey JM, Pestana A (1993) Chromosome 22 heterozygosity is retained in most hyperdiploid and pseudodiploid meningiomas. Cancer Genet Cytogenet 66:117–119PubMedCrossRef Bello MJ, de Campos JM, Vaquero J, Kusak ME, Sarasa JL, Rey JM, Pestana A (1993) Chromosome 22 heterozygosity is retained in most hyperdiploid and pseudodiploid meningiomas. Cancer Genet Cytogenet 66:117–119PubMedCrossRef
3.
go back to reference Bello MJ, de Campos JM, Kusak ME, Vaquero J, Sarasa JL, Pestana A, Rey JA (1994) Allelic loss at 1p is associated with tumor progression of meningiomas. Genes Chromosomes Cancer 9:296–298PubMedCrossRef Bello MJ, de Campos JM, Kusak ME, Vaquero J, Sarasa JL, Pestana A, Rey JA (1994) Allelic loss at 1p is associated with tumor progression of meningiomas. Genes Chromosomes Cancer 9:296–298PubMedCrossRef
4.
go back to reference Ketter R, Henn W, Niedermayer I, Steilen-Gimbel H, König J, Zang KD, Steudel WI (2001) Predictive value of progression-associated chromosome aberrations for the prognosis of meningiomas: a retrospective study of 198 cases. J Neurosurg 95:601–607PubMed Ketter R, Henn W, Niedermayer I, Steilen-Gimbel H, König J, Zang KD, Steudel WI (2001) Predictive value of progression-associated chromosome aberrations for the prognosis of meningiomas: a retrospective study of 198 cases. J Neurosurg 95:601–607PubMed
5.
go back to reference Kolles H, Niedermayer I, Schmitt C, Henn W, Feld R, Steudel WI, Zang KD, Feiden W (1995) Triple approach for diagnosis and grading of meningiomas: histology, morphometry of Ki-67/Feulgen stainings, and cytogenetics. Acta Neurochir 137:174–181CrossRef Kolles H, Niedermayer I, Schmitt C, Henn W, Feld R, Steudel WI, Zang KD, Feiden W (1995) Triple approach for diagnosis and grading of meningiomas: histology, morphometry of Ki-67/Feulgen stainings, and cytogenetics. Acta Neurochir 137:174–181CrossRef
6.
go back to reference Zang KD (1982) Cytological and cytogenetical studies on human meningioma. Cancer Genet Cytogenet 6:249–274PubMedCrossRef Zang KD (1982) Cytological and cytogenetical studies on human meningioma. Cancer Genet Cytogenet 6:249–274PubMedCrossRef
7.
go back to reference Sayagues JM, Tabernero MD, Maillo A, Espinosa A, Rasillo A, Diaz P, Ciudad J, Lopez A, Merino M, Goncalves JM, Santos-Briz A, Morales F, Orfao A (2004) Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?. J Mol Diagn 6:316–325PubMed Sayagues JM, Tabernero MD, Maillo A, Espinosa A, Rasillo A, Diaz P, Ciudad J, Lopez A, Merino M, Goncalves JM, Santos-Briz A, Morales F, Orfao A (2004) Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?. J Mol Diagn 6:316–325PubMed
8.
go back to reference Zankl H, Singer H, Zang KD (1971) Cytological and cytogenetical studies on brain tumors. II. Hyperdiploidy, a rare event in human primary meningiomas. Humangenetik 11:253–257PubMedCrossRef Zankl H, Singer H, Zang KD (1971) Cytological and cytogenetical studies on brain tumors. II. Hyperdiploidy, a rare event in human primary meningiomas. Humangenetik 11:253–257PubMedCrossRef
9.
go back to reference Adegbite AB, Khan MI, Paine KWE, Tan LK (1983) The recurrence of intracranial meningiomas after surgical treatment. J Neurosurg 58:51–56PubMed Adegbite AB, Khan MI, Paine KWE, Tan LK (1983) The recurrence of intracranial meningiomas after surgical treatment. J Neurosurg 58:51–56PubMed
10.
go back to reference Arnoldus EP, Wolters LB, Voormolen JH, van Diunen SG, Raap AK, van der Ploeg M, Peters AC (1992) Interphase cytogenetics: a new tool for study of genetic changes in brain tumors. J Neurosurg 76:997–1003PubMedCrossRef Arnoldus EP, Wolters LB, Voormolen JH, van Diunen SG, Raap AK, van der Ploeg M, Peters AC (1992) Interphase cytogenetics: a new tool for study of genetic changes in brain tumors. J Neurosurg 76:997–1003PubMedCrossRef
11.
go back to reference Scholz M, Gottschalk J, Striepecke E, Firsching R, Harders A, Füzesi L (1996) Intratumorous heterogeneity of chromosomes 10 and 17 in meningiomas using non-radioactive in situ hybridization. J Neurosurg Sci 40:17–23PubMed Scholz M, Gottschalk J, Striepecke E, Firsching R, Harders A, Füzesi L (1996) Intratumorous heterogeneity of chromosomes 10 and 17 in meningiomas using non-radioactive in situ hybridization. J Neurosurg Sci 40:17–23PubMed
12.
go back to reference Maillo A, Diaz P, Sayagues JM, Blanco A, Tabernero MD, Ciudad J, Lopez A, Goncalves JM, Orfao A (2001) Gains of chromosome 22 by fluorescence in situ hybridization in the context of an hyperdiploid karyotype are associated with aggressive clinical features in meningioma patients. Cancer 92:377–385PubMedCrossRef Maillo A, Diaz P, Sayagues JM, Blanco A, Tabernero MD, Ciudad J, Lopez A, Goncalves JM, Orfao A (2001) Gains of chromosome 22 by fluorescence in situ hybridization in the context of an hyperdiploid karyotype are associated with aggressive clinical features in meningioma patients. Cancer 92:377–385PubMedCrossRef
13.
go back to reference Steudel WI, Feld R, Henn W, Zang KD (1996) Correlation between cytogenetic and clinical findings in 215 human meningiomas. Acta Neurochir Suppl 65:73–76PubMed Steudel WI, Feld R, Henn W, Zang KD (1996) Correlation between cytogenetic and clinical findings in 215 human meningiomas. Acta Neurochir Suppl 65:73–76PubMed
14.
go back to reference Olivecrona H (1934) Die parasagittalen Meningiome. Thieme, Leipzig Olivecrona H (1934) Die parasagittalen Meningiome. Thieme, Leipzig
15.
go back to reference Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurochem 20:22–39 Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurochem 20:22–39
16.
go back to reference Limon J, Dal Cin P, Sandberg AA (1986) Application of long-term collagenase disaggregation for the cytogenetic analysis of human solid tumors. Cancer Genet Cytogenet 23:305–313PubMedCrossRef Limon J, Dal Cin P, Sandberg AA (1986) Application of long-term collagenase disaggregation for the cytogenetic analysis of human solid tumors. Cancer Genet Cytogenet 23:305–313PubMedCrossRef
17.
go back to reference Schröck E, Padilla-Nash H (2000) Spectral karyotyping and multicolor fluorescence in situ hybridization reveal new tumor-specific chromosomal aberrations. Semin Hematol 37:334–347PubMedCrossRef Schröck E, Padilla-Nash H (2000) Spectral karyotyping and multicolor fluorescence in situ hybridization reveal new tumor-specific chromosomal aberrations. Semin Hematol 37:334–347PubMedCrossRef
18.
go back to reference Louis DN, Scheithauer BW, Budka H, von Deimling A, Kepes JJ (2000) Meningiomas. In: Kleihues P, Cavenee WK (eds) Pathology and genetics of tumours of the nervous system. IARC, Lyon, pp 176–184 Louis DN, Scheithauer BW, Budka H, von Deimling A, Kepes JJ (2000) Meningiomas. In: Kleihues P, Cavenee WK (eds) Pathology and genetics of tumours of the nervous system. IARC, Lyon, pp 176–184
19.
go back to reference Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM (1998) The prognostic significance of MIB-1, p53 and DNA flow cytometry in completely resected primary meningiomas. Cancer 82:2262–2269PubMedCrossRef Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM (1998) The prognostic significance of MIB-1, p53 and DNA flow cytometry in completely resected primary meningiomas. Cancer 82:2262–2269PubMedCrossRef
20.
go back to reference Perry A, Gutmann DH, Reifenberger G (2004) Molecular pathogenesis of meningiomas. J Neurooncol 70:183–302PubMedCrossRef Perry A, Gutmann DH, Reifenberger G (2004) Molecular pathogenesis of meningiomas. J Neurooncol 70:183–302PubMedCrossRef
21.
go back to reference Niedermayer I, Feiden W, Henn W, Steilen-Gimbel H, Steudel WI, Zang KD (1997) Loss of alkaline phosphatase activity in meningiomas: a rapid histochemical technique indicating progression-associated deletion of a putative tumor suppressor gene on the distal part of the short arm of chromosome 1. J Neuropathol Exp Neurol 56:879–886PubMed Niedermayer I, Feiden W, Henn W, Steilen-Gimbel H, Steudel WI, Zang KD (1997) Loss of alkaline phosphatase activity in meningiomas: a rapid histochemical technique indicating progression-associated deletion of a putative tumor suppressor gene on the distal part of the short arm of chromosome 1. J Neuropathol Exp Neurol 56:879–886PubMed
23.
go back to reference Beerenwinkel N, Rahnenführer J, Däumer M, Hoffmann D, Kaiser R, Selbig J, Lengauer T (2005) Learning multiple evolutionary pathways from cross-sectional data. J Comput Biol 12(6):584–598PubMedCrossRef Beerenwinkel N, Rahnenführer J, Däumer M, Hoffmann D, Kaiser R, Selbig J, Lengauer T (2005) Learning multiple evolutionary pathways from cross-sectional data. J Comput Biol 12(6):584–598PubMedCrossRef
24.
go back to reference Beerenwinkel N, Rahnenführer J, Kaiser R, Hoffmann D, Selbig J, Lengauer T (2005) Mtreemix: a software package for learning and use mixture models of mutagenetic trees. Bioinformatics 21(9):2106–2107PubMedCrossRef Beerenwinkel N, Rahnenführer J, Kaiser R, Hoffmann D, Selbig J, Lengauer T (2005) Mtreemix: a software package for learning and use mixture models of mutagenetic trees. Bioinformatics 21(9):2106–2107PubMedCrossRef
25.
go back to reference Rahnenführer R, Beerenwinkel N, Schulz WA, Hartmann C, von Deimling A, Wullich B, Lengauer T (2005) Estimating cancer survival and clinical outcome based on genetic tumor progression scores. Bioinformatics 21:2438–2446PubMedCrossRef Rahnenführer R, Beerenwinkel N, Schulz WA, Hartmann C, von Deimling A, Wullich B, Lengauer T (2005) Estimating cancer survival and clinical outcome based on genetic tumor progression scores. Bioinformatics 21:2438–2446PubMedCrossRef
26.
go back to reference Zülch KJ (1979) Histological typing of tumors of the central nervous system. World Health Organization, Geneva Zülch KJ (1979) Histological typing of tumors of the central nervous system. World Health Organization, Geneva
27.
go back to reference Menon AG, Rutter JL, von Sattel JP, Snyder H, Murdoch C, Blumenfeld A, Martuza RL, von Deimling A, Gusella JF, Houseal TW (1997) Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative “tumor progression” locus. Oncogene 14:611–616PubMedCrossRef Menon AG, Rutter JL, von Sattel JP, Snyder H, Murdoch C, Blumenfeld A, Martuza RL, von Deimling A, Gusella JF, Houseal TW (1997) Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative “tumor progression” locus. Oncogene 14:611–616PubMedCrossRef
28.
go back to reference Cushing H (1922) The cranial hyperostoses produced by meningeal endotheliomas. Arch Neurol Psychiatry 8:139–152 Cushing H (1922) The cranial hyperostoses produced by meningeal endotheliomas. Arch Neurol Psychiatry 8:139–152
29.
go back to reference Zankl H, Zang KD (1980) Correlation between clinical and cytogenetical data in 180 human meningiomas. Cancer Genet Cytogenet 1:351–356CrossRef Zankl H, Zang KD (1980) Correlation between clinical and cytogenetical data in 180 human meningiomas. Cancer Genet Cytogenet 1:351–356CrossRef
30.
go back to reference Simon M, von Deimling A, Larson JJ, Wellenreuther R, Kaskel P, Waha A, Warnick RE, Tew JM Jr, Menon AG (1995) Allelic loss on chromosomes 14, 10 and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression. Cancer Res 55:4696–4701PubMed Simon M, von Deimling A, Larson JJ, Wellenreuther R, Kaskel P, Waha A, Warnick RE, Tew JM Jr, Menon AG (1995) Allelic loss on chromosomes 14, 10 and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression. Cancer Res 55:4696–4701PubMed
31.
go back to reference Zang KD (2001) Meningioma: a cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases. Cytogenet Cell Genet 293:207–220CrossRef Zang KD (2001) Meningioma: a cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases. Cytogenet Cell Genet 293:207–220CrossRef
32.
go back to reference Wellenreuther R, Kraus JA, Lenartz D, Menon G, Schramm J, Louis DN, Ramesh V, Gusella JF, Wiestler OD, von Deimling A (1995) Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am J Pathol 146:827–832PubMed Wellenreuther R, Kraus JA, Lenartz D, Menon G, Schramm J, Louis DN, Ramesh V, Gusella JF, Wiestler OD, von Deimling A (1995) Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am J Pathol 146:827–832PubMed
33.
go back to reference Bouvier C, Liprandi A, Colin C, Giorgi R, Quilichini B, Metellus P, Figarella-Branger D (2005) Lack of alkaline phosphatase activity predicts meningioma recurrence. Am J Clin Pathol 124:252–258PubMedCrossRef Bouvier C, Liprandi A, Colin C, Giorgi R, Quilichini B, Metellus P, Figarella-Branger D (2005) Lack of alkaline phosphatase activity predicts meningioma recurrence. Am J Clin Pathol 124:252–258PubMedCrossRef
Metadata
Title
Hyperdiploidy defines a distinct cytogenetic entity of meningiomas
Authors
Ralf Ketter
Yoo-Jin Kim
Simone Storck
Jörg Rahnenführer
Bernd F. M. Romeike
Wolf-Ingo Steudel
Klaus D. Zang
Wolfram Henn
Publication date
01-06-2007
Published in
Journal of Neuro-Oncology / Issue 2/2007
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-006-9318-7

Other articles of this Issue 2/2007

Journal of Neuro-Oncology 2/2007 Go to the issue